Co-Authors
This is a "connection" page, showing publications co-authored by ERIC TANIFUM and ANDREW BADACHHAPE.
Connection Strength
1.562
-
A dual target molecular magnetic resonance imaging probe for noninvasive profiling of pathologic alpha-synuclein and microgliosis in a mouse model of Parkinson's disease. Front Neurosci. 2024; 18:1428736.
Score: 0.248
-
Rational Design of a Self-Assembling High Performance Organic Nanofluorophore for Intraoperative NIR-II Image-Guided Tumor Resection of Oral Cancer. Adv Sci (Weinh). 2023 04; 10(10):e2206435.
Score: 0.224
-
Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
Score: 0.218
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.190
-
Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
Score: 0.180
-
Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
Score: 0.169
-
A Hyperfluorinated Hydrophilic Molecule for Aqueous 19F MRI Contrast Media. Contrast Media Mol Imaging. 2018; 2018:1693513.
Score: 0.167
-
Advances in nanoprobes for molecular MRI of Alzheimer's disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr; 16(2):e1946.
Score: 0.060
-
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
Score: 0.054
-
Nanoprobes for Computed Tomography and Magnetic Resonance Imaging in Atherosclerosis Research. Methods Mol Biol. 2022; 2419:809-823.
Score: 0.052